Identity
- Trade Name
- TORUS Stent Graft System FDA UDI
- Generic Name
- Central/peripheral venous endovascular stent-graft FDA UDI
- Device Name
- The DETOUR System is indicated for use for percutaneous revascularization in patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis >70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments. The DETOUR System, or any of its components, is not for use in the coronary and cerebral vasculature FDA UDI
- Model / Reference
- TSG-6.0X200 FDA UDI
- Description
- The DETOUR System is indicated for use for percutaneous revascularization in patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis >70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments. The DETOUR System, or any of its components, is not for use in the coronary and cerebral vasculature FDA UDI
Identifiers
- Catalog Number
- TSG-6.0X200 FDA UDI
- Primary DI / UDI-DI
- 00860008946447 FDA UDI
- PMA Number
- P220021 FDA UDI
- FDA Product Code
- QWM FDA UDI
- GMDN Term
- Central/peripheral venous endovascular stent-graft FDA UDI
Classification
- Device Class
- Class III FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
MR Conditional FDA UDI
Category: Central/peripheral venous endovascular stent-graft
TORUS Stent Graft System by PQ Bypass, Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Central/peripheral venous endovascular stent-graft.
- Fluency® Endovascular Stent Graft — Bard Peripheral Vascular · Class III
- Fluency® Endovascular Stent Graft — Bard Peripheral Vascular · Class III
- Fluency® Endovascular Stent Graft — Bard Peripheral Vascular · Class III
- Fluency® Endovascular Stent Graft — Bard Peripheral Vascular · Class III
- COVERA — Angiomed GmbH & Co. Medizintechnik KG · Class III
- COVERA — Angiomed GmbH & Co. Medizintechnik KG · Class III
- Fluency® Endovascular Stent Graft — Bard Peripheral Vascular · Class III
- Fluency® Endovascular Stent Graft — Bard Peripheral Vascular · Class III
Cleared under the same submission
P220021 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class III | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- PQ Bypass, Inc.
Sources (1)
- FDA UDI 26bc7360-5f04-4713-86cd-4cbaeb420387 38 fields · synced May 30, 2026